Making sense of refractive surgery in 2001: why, when, for whom, and by whom?

Department of Ophthalmology, University of California Davis, Sacramento, USA.
Mayo Clinic Proceedings (Impact Factor: 5.81). 09/2001; 76(8):823-9. DOI: 10.1016/S0025-6196(11)63227-8
Source: PubMed

ABSTRACT Surgical alteration of the focusing or refractive properties of the eye has been performed on millions of patients. An array of procedures to correct myopia, hyperopia, astigmatism, and presbyopia have been introduced over the past 25 years with varying degrees of success. Improved technology has increased patient and physician satisfaction and enthusiasm. Currently available surgical procedures can be categorized as incisional, surface-altering, lamellar, and intraocular. The choice of procedure depends on individual patient indications and contraindications based on results of ocular examinations, eg, corneal pachymetry to measure corneal thickness, keratometry to measure the corneal curvature, basal tear secretory rate, and dark-adapted pupil size. The postoperative uncorrected visual acuity depends, in large part, on the quality of the preoperative evaluation and refraction. Before scheduling a patient for surgery, the ophthalmologist must ensure that the patient understands the potential risks of the procedure and has realistic expectations for the postoperative level and quality of uncorrected visual acuity. Postoperative complications include corneal flap displacement, undercorrection and overcorrection, and epithelial ingrowth under the corneal flap and inflammatory keratitis. Postoperative dry eye, infection, and inflammation are usually treated medically. Ongoing technological innovations to customize the surgical approach to an individual patient's eye continue to improve outcomes.

  • The Journal of Surgery 01/2004; 2(1):34-37. DOI:10.1016/S1743-9191(06)60024-1 · 1.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the relationship between the achieved refractive change and the change in simulated keratometry (K) after myopic laser situ keratomileusis (LASIK) and compare this relationship between custom and conventional treatments. Department of Ophthalmology, University of California, Davis, Sacramento, California, and John A. Moran Eye Center, Salt Lake City, Utah, USA. The change in simulated K and the refractive change induced by custom myopic LASIK and conventional LASIK were determined. The relationship between the variables was analyzed by regression methods. Custom treatment was performed in 106 eyes and conventional treatment in 224 eyes. Simple linear regression analysis did not fit the clinical observation when the refractive change was less than 2.00 diopters (D) of myopic correction with both treatments. Under the linear model and nonlinear model, each unit of refractive change yielded a greater change in corneal topographic power with custom treatment than with conventional treatment. With both treatments, the rate of change in simulated K was not constant and was much more variable with lower amounts of correction. The relationship was more constant and linear with larger amounts of refractive correction. The relationship between the measured change in simulated K and the induced refractive change better fit a nonlinear relationship with smaller amounts of refractive correction in custom LASIK and conventional LASIK. Under all forms of analysis, custom treatments yielded a greater per-unit change in corneal curvature than conventional treatments, especially for refractive corrections of 4.00 D and higher.
    Journal of Cataract and Refractive Surgery 09/2010; 36(9):1550-5. DOI:10.1016/j.jcrs.2010.04.027 · 2.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To identify differentially expressed genes in healing mouse corneas by using cDNA microarrays. Transepithelial excimer laser ablations were performed on mouse corneas, and the wounds were allowed to heal partially in vivo for 18 to 22 hours. Total RNA was isolated from both normal and healing corneas and was used for synthesis of cDNA probes. 33P-labeled exponential cDNA probes were hybridized to mouse cDNA nylon arrays. Of the 1176 genes on the nylon arrays, the expression of 37 was upregulated and that of 27 was downregulated more than fivefold in the healing corneas compared with the normal, uninjured corneas. Interleukin (IL)-1beta, laminin-5, and thrombospondin-1, which have been shown to be upregulated in healing corneas, were all found to be induced in the corneas in response to excimer laser treatment. Many genes were identified for the first time to be differentially regulated during corneal wound healing. Among the upregulated genes were intercellular adhesion molecule (ICAM)-1, macrophage inflammatory proteins, suppressors of cytokine signaling proteins (SOCS), IL-10 receptor, and galectin-7. Among the downregulated genes were connexin-31, a gap junction protein; ZO1 and occludin, tight junction proteins; and Smad2, a key component in the TGFbeta signaling pathway. Microarray data were validated on a limited number of genes by semiquantitative RT-PCR and Western blot analyses. Gene array technology was used to identify for the first time many genes that are differentially regulated during corneal wound healing. These differentially expressed genes have not previously been investigated in the context of wound healing and represent novel factors for further study of the mechanism of wound healing.
    Investigative Ophthalmology &amp Visual Science 10/2002; 43(9):2897-904. · 3.66 Impact Factor


1 Download